Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Nicoletti

Showing results (511-520 of 548) with videos related to

Pageof 55
Sort By:
The Journal of Clinical Investigation|February 11, 2020
D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's diseaseIrene Sebastianutto, Elise Goyet, Laura Andreoli, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2012
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberineWilliam H Chappell, Stephen L Abrams, Richard A Franklin, et al.
Ebiomedicine|April 15, 2025
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistanceMaria Mirabelli, Eusebio Chiefari, Biagio Arcidiacono, et al.
Journal of Cellular Physiology|February 9, 2011
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathwaysJames A McCubrey, Linda S Steelman, C Ruth Kempf, et al.
Neuropharmacology|July 1, 2023
Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autismLuisa Di Menna, Rosamaria Orlando, Giovanna D'Errico, et al.
Molecular Pharmacology|December 17, 2010
Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotectiveFilippo Caraci, Gemma Molinaro, Giuseppe Battaglia, et al.
Journal of Clinical Medicine|January 11, 2022
Canonical (CD74/CD44) and Non-Canonical (CXCR2, 4 and 7) MIF Receptors Are Differentially Expressed in Rheumatoid Arthritis Patients Evaluated by DAS28-ESRGabriela Athziri Sánchez-Zuno, Richard Bucala, Jorge Hernández-Bello, et al.
Psychiatry Investigation|March 8, 2014
Low-dose acetazolamide in the treatment of premenstrual dysphoric disorder: a case seriesGabriele Sani, Georgios D Kotzalidis, Isabella Panaccione, et al.
Elife|April 12, 2017
Optical control of pain <i>in vivo</i> with a photoactive mGlu<sub>5</sub> receptor negative allosteric modulatorJoan Font, Marc López-Cano, Serena Notartomaso, et al.
Neurobiology of Stress|December 21, 2020
Maternal stress programs accelerated aging of the basal ganglia motor system in offspringJordan Marrocco, Remy Verhaeghe, Domenico Bucci, et al.
Pageof 55

Showing results (511-520 of 548) with videos related to

Sort By:
Pageof 55
The Journal of Clinical Investigation|February 11, 2020
D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's diseaseIrene Sebastianutto, Elise Goyet, Laura Andreoli, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2012
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberineWilliam H Chappell, Stephen L Abrams, Richard A Franklin, et al.
Ebiomedicine|April 15, 2025
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistanceMaria Mirabelli, Eusebio Chiefari, Biagio Arcidiacono, et al.
Journal of Cellular Physiology|February 9, 2011
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathwaysJames A McCubrey, Linda S Steelman, C Ruth Kempf, et al.
Neuropharmacology|July 1, 2023
Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autismLuisa Di Menna, Rosamaria Orlando, Giovanna D'Errico, et al.
Molecular Pharmacology|December 17, 2010
Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotectiveFilippo Caraci, Gemma Molinaro, Giuseppe Battaglia, et al.
Journal of Clinical Medicine|January 11, 2022
Canonical (CD74/CD44) and Non-Canonical (CXCR2, 4 and 7) MIF Receptors Are Differentially Expressed in Rheumatoid Arthritis Patients Evaluated by DAS28-ESRGabriela Athziri Sánchez-Zuno, Richard Bucala, Jorge Hernández-Bello, et al.
Psychiatry Investigation|March 8, 2014
Low-dose acetazolamide in the treatment of premenstrual dysphoric disorder: a case seriesGabriele Sani, Georgios D Kotzalidis, Isabella Panaccione, et al.
Elife|April 12, 2017
Optical control of pain <i>in vivo</i> with a photoactive mGlu<sub>5</sub> receptor negative allosteric modulatorJoan Font, Marc López-Cano, Serena Notartomaso, et al.
Neurobiology of Stress|December 21, 2020
Maternal stress programs accelerated aging of the basal ganglia motor system in offspringJordan Marrocco, Remy Verhaeghe, Domenico Bucci, et al.
Pageof 55